Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest announcement is out from Calidi Biotherapeutics (CLDI).
George Ng, a board member of Calidi Biotherapeutics, will not seek re-election at the 2024 annual shareholder meeting due to increasing external professional commitments. However, he will maintain a strategic advisory role with the company. His departure is amicable, without disputes over company operations, policies, or practices. Consequently, the board will downsize from six to five members following his term’s expiration.
Learn more about CLDI stock on TipRanks’ Stock Analysis page.